Mayo Clinic: “Benign prostatic hyperplasia: Definition” “Benign prostatic hyperplasia: Treatments and Drugs,” “Minimally invasive surgery: Definition.”
Urology Care Foundation: “What Are the Symptoms of BPH?” “Benign Prostatic Hyperplasia (BPH): Surgery,” “BPH: Minimally Invasive Surgeries,” “What is Transurethral Electroevaporation of the Prostate (TUVP)?”
UCLA Health: “Conditions Treated: BPH.”
Treatments for Benign Prostatic Hyperplasia (BPH)
Food & Drug Administration: “5-alpha reductase inhibitors (5-ARIs): Label Change - Increased Risk of Prostate Cancer.”
National Institutes of Health, National Center for Complementary and Integrative Health: “Saw Palmetto.”
American Urological Association: “Benign Prostatic Hyperplasia (BPH): A Patient's Guide,” “Benign Prostatic Hyperplasia (BPH), Clinical Guidelines.”
Agency for Healthcare Policy Research.
William Jaffe, MD, professor of urology, Temple University School of Medicine, Philadelphia.
National Kidney and Urologic Diseases Information Clearinghouse (NKUDIC): “Prostate Enlargement: Benign Prostatic Hyperplasia.”
BJU International: “High-grade prostate cancer and finasteride.”
Winchester Hospital: “Health Library: Saw Palmetto”
Casabé A, Roehrborn CG, Da Pozzo LF, et al.
"Efficacy and safety of the coadministration of tadalafil once daily with finasteride for 6 months in men with lower urinary tract symptoms and prostatic enlargement secondary to benign prostatic hyperplasia." J Urol.2014;191:727-733
Porst H, Kim ED, Casabé AR, et al. "Efficacy and safety of tadalafil once daily in the treatment of men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia: results of an international randomized, double-blind, placebo-controlled trial." Eur Urol.2011;60:1105-1113.